| 1 |
Geppe NA, Zaplatnikov AL, Kondyurina EG, Chepurnaya MM, Kolosova NG. The Common Cold and Influenza in Children: To Treat or Not to Treat? Microorganisms 2023;11:858. [DOI: 10.3390/microorganisms11040858] [Reference Citation Analysis]
|
| 2 |
Numata M, Sajuthi S, Bochkov YA, Loeffler J, Everman J, Vladar EK, Cooney RA, Reinhardt RL, Liu AH, Seibold MA, Voelker DR. Anionic Pulmonary Surfactant Lipid Treatment Inhibits Rhinovirus A Infection of the Human Airway Epithelium. Viruses 2023;15:747. [DOI: 10.3390/v15030747] [Reference Citation Analysis]
|
| 3 |
Wong A, Barrero Guevara LA, Goult E, Briga M, Kramer SC, Kovacevic A, Opatowski L, Domenech de Cellès M. The interactions of SARS-CoV-2 with cocirculating pathogens: Epidemiological implications and current knowledge gaps. PLoS Pathog 2023;19:e1011167. [PMID: 36888684 DOI: 10.1371/journal.ppat.1011167] [Reference Citation Analysis]
|
| 4 |
Chow EJ, Uyeki TM, Chu HY. The effects of the COVID-19 pandemic on community respiratory virus activity. Nat Rev Microbiol 2023;21:195-210. [PMID: 36253478 DOI: 10.1038/s41579-022-00807-9] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 11.0] [Reference Citation Analysis]
|
| 5 |
Essaidi-Laziosi M, Royston L, Boda B, Pérez-Rodriguez FJ, Piuz I, Hulo N, Kaiser L, Clément S, Huang S, Constant S, Tapparel C. Altered cell function and increased replication of rhinoviruses and EV-D68 in airway epithelia of asthma patients. Front Microbiol 2023;14:1106945. [PMID: 36937308 DOI: 10.3389/fmicb.2023.1106945] [Reference Citation Analysis]
|
| 6 |
Dee K, Schultz V, Haney J, Bissett LA, Magill C, Murcia PR. Influenza A and respiratory syncytial virus trigger a cellular response that blocks severe acute respiratory syndrome virus 2 infection in the respiratory tract. J Infect Dis 2022:jiac494. [PMID: 36550077 DOI: 10.1093/infdis/jiac494] [Reference Citation Analysis]
|
| 7 |
Du Y, Wang C, Zhang Y. Viral Coinfections. Viruses 2022;14. [PMID: 36560647 DOI: 10.3390/v14122645] [Reference Citation Analysis]
|
| 8 |
Czerkies M, Kochańczyk M, Korwek Z, Prus W, Lipniacki T. Respiratory Syncytial Virus Protects Bystander Cells against Influenza A Virus Infection by Triggering Secretion of Type I and Type III Interferons. J Virol 2022. [DOI: 10.1128/jvi.01341-22] [Reference Citation Analysis]
|
| 9 |
Medaglia C, Kolpakov I, Zwygart AC, Zhu Y, Constant S, Huang S, Cagno V, Dermitzakis ET, Stellacci F, Xenarios I, Tapparel C. An anti-influenza combined therapy assessed by single cell RNA-sequencing. Commun Biol 2022;5:1075. [PMID: 36216966 DOI: 10.1038/s42003-022-04013-4] [Reference Citation Analysis]
|
| 10 |
Jones RP, Ponomarenko A. Roles for Pathogen Interference in Influenza Vaccination, with Implications to Vaccine Effectiveness (VE) and Attribution of Influenza Deaths. Infectious Disease Reports 2022;14:710-58. [DOI: 10.3390/idr14050076] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 11 |
Corsello T, Qu Y, Ivanciuc T, Garofalo RP, Casola A. Antiviral activity of extracellular vesicles derived from respiratory syncytial virus-infected airway epithelial cells. Front Immunol 2022;13:886701. [DOI: 10.3389/fimmu.2022.886701] [Reference Citation Analysis]
|
| 12 |
Takashima MD, Grimwood K, Sly PD, Lambert SB, Ware RS. Interference between rhinovirus and other RNA respiratory viruses in the first 2-years of life: A longitudinal community-based birth cohort study. J Clin Virol 2022;155:105249. [PMID: 35939878 DOI: 10.1016/j.jcv.2022.105249] [Reference Citation Analysis]
|
| 13 |
Alexander P, Dobrovolny HM. Treatment of Respiratory Viral Coinfections. Epidemiologia (Basel) 2022;3:81-96. [PMID: 36417269 DOI: 10.3390/epidemiologia3010008] [Reference Citation Analysis]
|
| 14 |
Fage C, Hénaut M, Carbonneau J, Piret J, Boivin G. Influenza A(H1N1)pdm09 Virus but Not Respiratory Syncytial Virus Interferes with SARS-CoV-2 Replication during Sequential Infections in Human Nasal Epithelial Cells. Viruses 2022;14:395. [DOI: 10.3390/v14020395] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 15 |
Hamamoto I, Shimasaki N; Influenza and Respiratory Virus Research Center, National Institute of Infectious Diseases (NIID) 4-7-1 Gakuen, Musashimurayama, Tokyo 208-0011, Japan, Department of Virology III, National Institute of Infectious Diseases (NIID), Tokyo, Japan. The Importance of Monitoring Viral Respiratory Infections During the COVID-19 Crisis. JDR 2022;17:73-81. [DOI: 10.20965/jdr.2022.p0073] [Reference Citation Analysis]
|
| 16 |
Tao KP, Chong MK, Chan KY, Pun JC, Tsun JG, Chow SM, Ng CS, Wang MH, Chan PK, Li AM, Chan RW. Suppression of influenza virus infection by rhinovirus interference – at the population, individual and cellular levels. Current Research in Microbial Sciences 2022;3:100147. [DOI: 10.1016/j.crmicr.2022.100147] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 17 |
Essaidi-Laziosi M PhD, Alvarez C MSc, Puhach O PhD, Sattonnet-Roche P, Torriani G PhD, Tapparel C PhD, Kaiser L MD, Eckerle I MD. Sequential infections with rhinovirus and influenza modulate the replicative capacity of SARS-CoV-2 in the upper respiratory tract. Emerg Microbes Infect 2021;:1-26. [PMID: 34931581 DOI: 10.1080/22221751.2021.2021806] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 18 |
Czerkies M, Kochańczyk M, Korwek Z, Prus W, Lipniacki T. RSV immunizes bystander cells to IAV infection using interferons β and λ.. [DOI: 10.1101/2021.10.11.463877] [Reference Citation Analysis]
|
| 19 |
Tao KP, Chong M, Pun JC, Tsun JG, Chow SM, Ng CS, Wang MH, Chan Z, Chan PK, Li AM, Chan RW. Suppression of influenza virus infection by rhinovirus interference at the population, individual and cellular levels.. [DOI: 10.1101/2021.08.09.21256656] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 20 |
Renzoni A, Perez F, Ngo Nsoga MT, Yerly S, Boehm E, Gayet-Ageron A, Kaiser L, Schibler M. Analytical Evaluation of Visby Medical RT-PCR Portable Device for Rapid Detection of SARS-CoV-2. Diagnostics (Basel) 2021;11:813. [PMID: 33947153 DOI: 10.3390/diagnostics11050813] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 21 |
Renson P, Deblanc C, Bougon J, Le Dimna M, Gorin S, Mahé S, Barbier N, Paboeuf F, Simon G, Bourry O. Concomitant Swine Influenza A Virus Infection Alters PRRSV1 MLV Viremia in Piglets but Does Not Interfere with Vaccine Protection in Experimental Conditions. Vaccines (Basel) 2021;9:356. [PMID: 33917103 DOI: 10.3390/vaccines9040356] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 22 |
Cheemarla NR, Watkins TA, Mihaylova VT, Wang B, Zhao D, Wang G, Landry ML, Foxman EF. Magnitude and timing of the antiviral response determine SARS-CoV-2 replication early in infection.. [DOI: 10.1101/2021.01.22.21249812] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 23 |
Geiser J, Boivin G, Huang S, Constant S, Kaiser L, Tapparel C, Essaidi-Laziosi M. RSV and HMPV Infections in 3D Tissue Cultures: Mechanisms Involved in Virus-Host and Virus-Virus Interactions. Viruses 2021;13:139. [PMID: 33478119 DOI: 10.3390/v13010139] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 24 |
Lozhkov AA, Klotchenko SA, Ramsay ES, Moshkoff HD, Moshkoff DA, Vasin AV, Salvato MS. The Key Roles of Interferon Lambda in Human Molecular Defense against Respiratory Viral Infections. Pathogens 2020;9:E989. [PMID: 33255985 DOI: 10.3390/pathogens9120989] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 25 |
Sridhar A, Simmini S, Ribeiro CMS, Tapparel C, Evers MM, Pajkrt D, Wolthers K. A Perspective on Organoids for Virology Research. Viruses 2020;12:E1341. [PMID: 33238561 DOI: 10.3390/v12111341] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 4.7] [Reference Citation Analysis]
|
| 26 |
Brendish NJ, Poole S, Naidu VV, Mansbridge CT, Norton N, Borca F, Phan HT, Wheeler H, Harvey M, Presland L, Clark TW. Clinical characteristics, symptoms and outcomes of 1054 adults presenting to hospital with suspected COVID-19: A comparison of patients with and without SARS-CoV-2 infection. J Infect 2020;81:937-43. [PMID: 32998038 DOI: 10.1016/j.jinf.2020.09.033] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 6.7] [Reference Citation Analysis]
|
